טוען...
Increased antimicrobial resistance during the COVID-19 pandemic
In addition to SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection itself, an increase in the incidence of antimicrobial resistance poses collateral damage to the current status of the COVID-19 (coronavirus disease 2019) pandemic. There has been a rapid increase in multidrug-resis...
שמור ב:
| הוצא לאור ב: | Int J Antimicrob Agents |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier Ltd and International Society of Antimicrobial Chemotherapy.
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7972869/ https://ncbi.nlm.nih.gov/pubmed/33746045 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijantimicag.2021.106324 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|